Literature DB >> 11704173

Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume.

I S Fraser1, P Warner, P A Marantos.   

Abstract

OBJECTIVE: To examine the relationship between total fluid volume at menstruation and the volume of blood loss, and to assess the feasibility of using total fluid volume to estimate menstrual blood loss.
METHODS: Fifty-three women were studied over two menstrual periods each. Hemoglobin in menstrual pads and tampons was measured using the alkaline hematin technique; total menstrual fluid volume was simultaneously measured using a weighing technique and meticulous care to avoid evaporation.
RESULTS: Despite period-to-period change in measured total menstrual fluid and menstrual blood loss volumes, there was a significant correlation between total fluid volume and blood loss (r =.93, P <.001). Blood comprised 48% of total menstrual flow for women with moderately heavy blood loss (>60 mL) and 50% for women with excessive blood loss (>100 mL). Regression estimation of blood loss from total fluid volume was reasonably accurate. For clinical purposes, estimated blood volumes correctly classified 98% of periods in terms of actual blood loss as normal (<60 mL blood), moderately heavy (60-100 mL), or excessive (>100 mL).
CONCLUSION: If total fluid volume is measured carefully, the estimate of actual blood loss is sufficiently accurate for clinical purposes. This simple technique has considerable clinical potential, and inexpensive commercial packs for this purpose could easily be developed.

Entities:  

Mesh:

Year:  2001        PMID: 11704173     DOI: 10.1016/s0029-7844(01)01581-2

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  20 in total

1.  Seasonal variation of haemoglobin mass in internationally competitive female road cyclists.

Authors:  Laura A Garvican; David T Martin; Warren McDonald; Christopher J Gore
Journal:  Eur J Appl Physiol       Date:  2010-01-08       Impact factor: 3.078

2.  mRNA profiling using a minimum of five mRNA markers per body fluid and a novel scoring method for body fluid identification.

Authors:  Amy D Roeder; Cordula Haas
Journal:  Int J Legal Med       Date:  2012-12-20       Impact factor: 2.686

3.  Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-09-19

Review 4.  Abnormal Uterine Bleeding in Adolescents

Authors:  Selin Elmaoğulları; Zeyra Aycan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-02-28

5.  Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production In Vitro.

Authors:  Louis Nonfoux; Myriam Chiaruzzi; Cédric Badiou; Jessica Baude; Anne Tristan; Jean Thioulouse; Daniel Muller; Claire Prigent-Combaret; Gérard Lina
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

6.  Menstrual symptoms: the importance of social factors in women's experiences.

Authors:  Norma O'Flynn
Journal:  Br J Gen Pract       Date:  2006-12       Impact factor: 5.386

7.  Depression in Collegiate Runners and Soccer Players: Relationships with Serum 25-Hydroxyvitamin D, Ferritin, and Fractures.

Authors:  Devin Tomlinson; Evan Eschker; Jade Callan; Tamara Hewbutler
Journal:  Int J Exerc Sci       Date:  2021-09-01

Review 8.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

Review 9.  Abnormal uterine bleeding: a review of patient-based outcome measures.

Authors:  Kristen A Matteson; Lori A Boardman; Malcolm G Munro; Melissa A Clark
Journal:  Fertil Steril       Date:  2008-07-16       Impact factor: 7.329

10.  Estimation of menstrual blood loss volume based on menstrual diary and laboratory data.

Authors:  Ulrike Schumacher; Jens Schumacher; Uwe Mellinger; Christoph Gerlinger; Andreas Wienke; Jan Endrikat
Journal:  BMC Womens Health       Date:  2012-08-20       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.